AbL Competitors

Stocks . France . 
Stock . AbL Diagnostics SA
ABLD Stock   2.40  0.10  4.00%   
AbL Diagnostics SA competes with Getlink SE, Compagnie, Compagnie, Amoeba SA, and Vallourec; as well as few others. The company operates under Industrials sector and is part of Railroads industry. Analyzing AbL Diagnostics competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of AbL Diagnostics to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out AbL Diagnostics Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of AbL Diagnostics competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.982.403.82
Details
Intrinsic
Valuation
LowRealHigh
1.102.523.94
Details

AbL Diagnostics Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between AbL Diagnostics and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of AbL and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of AbL Diagnostics SA does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
VK
+ 0.91
ALMIB
VK
+ 0.83
SGO
ALO
+ 0.83
ALMIB
ALO
+ 0.82
VK
ALO
+ 0.79
SGO
TE
+ 0.79
VK
  
High negative correlations   
ABCA
- 0.64
GET
TE
- 0.6
GET
VK
- 0.54
GET
ALO
- 0.52
GET
ALMIB
- 0.51
GET
TE
- 0.4
CBDG

Risk-Adjusted Indicators

There is a big difference between AbL Stock performing well and AbL Diagnostics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze AbL Diagnostics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

AbL Diagnostics Competitive Analysis

The better you understand AbL Diagnostics competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, AbL Diagnostics' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across AbL Diagnostics' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
ABLD GET CBDG SGO ALMIB VK ALO ABCA TE
 4.00 
 2.40 
AbL
 0.46 
 15.41 
Getlink
 3.81 
 101.00 
Compagnie
 0.19 
 85.60 
Compagnie
 2.22 
 0.88 
Amoeba
 0.49 
 16.35 
Vallourec
 1.33 
 21.55 
Alstom
 0.63 
 4.71 
ABC
 0.24 
 25.26 
Technip
Market Volatility
(90 Days Market Risk)
Slightly risky
Very steady
Out of control
Very steady
Abnormally volatile
Very steady
Not too volatile
Somewhat reliable
Not too volatile
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Solid
Insignificant
Solid
Good
OK
Modest
OK
Odds of Financial Distress
(Probability Of Bankruptcy)
Quite High
Below Average
Below Average
Low
Low
Below Average
Below Average
Low
Low
Current Valuation
(Equity Enterprise Value)
Under Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Under Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Cautious Hold
Cautious Hold
Strong Sell
Strong Sell
Strong Sell
Strong Buy
Strong Sell
Sell
Strong Sell
Current Ratio
N/A
2.41
18.2
1.44
2.97
0.61
0.74
26.56
0.84
Net Asset
2.71 M
8.15 B
4.52 B
55.38 B
14.52 M
4.75 B
30.52 B
185.2 M
8.38 B
Profit Margin
N/A
0.16
80.0
0.0587
N/A
-0.0807
-0.0358
0.45
0.0434
EBITDA
N/A
(72.67 M)
21.4 M
6.81 B
(4.46 M)
462.08 M
359 M
37.12 M
507.6 M
Current Valuation
26.3 M
13.17 B
2.11 B
31.14 B
40.89 M
3.63 B
11.95 B
270.38 M
(55.3 M)
Price To Book
11.59
4.26
0.86
1.02
10.62
1.54
0.95
2.37
1.76
Operating Margin
N/A
0.42
-4.5
0.1
N/A
0.0721
0.0123
0.52
0.0827
Retained Earnings
N/A
100 M
N/A
10.8 B
N/A
(415 M)
1.61 B
24 M
N/A
Current Asset
N/A
667 M
4 B
17.55 B
N/A
3.48 B
7.95 B
150 M
N/A
Five Year Return
N/A
2.33
1.2
3.1
N/A
2.67
N/A
5.45
N/A
Beta
-0.13
0.89
0.61
1.41
0.22
2.62
1.07
0.23
0.76
Number Of Employees
1
10
4
11
18
17 K
69.32 K
90
15 K
Shares Outstanding
2.01 M
540.5 M
559.74 K
512.3 M
46.27 M
231.63 M
376.22 M
59.14 M
175.15 M
Cash Flow From Operations
(56.69 K)
351.48 M
3.5 M
5.71 B
(4.26 M)
(145.81 M)
(577 M)
34.05 M
934.4 M
Annual Yield
N/A
0.0063
0.0275
0.0359
N/A
N/A
0.0091
0.0625
0.0245
Total Debt
N/A
5.18 B
N/A
8.76 B
268.74 K
1.39 B
3.23 B
N/A
831 M
Return On Equity
-0.0612
0.13
0.0017
0.14
-3.49
-0.2
-0.0587
0.17
0.19
Z Score
N/A
0.6
N/A
1.8
76.2
1.2
1.8
N/A
1.8
Return On Asset
-0.0402
0.0497
-1.0E-4
0.0551
-0.29
0.0393
0.004
0.11
0.0392
Book Value Per Share
1.25
3.68
6541.31
44.32
0.15
8.84
24.66
2.72
8.95
Current Liabilities
N/A
335 M
3.71 B
12.62 B
N/A
2.46 B
7.28 B
11 M
N/A
Total Asset
2.71 M
8.15 B
4.52 B
55.38 B
14.52 M
4.75 B
30.52 B
185.2 M
8.38 B
Debt To Equity
N/A
4.57
0.9
0.73
4.23
N/A
0.32
N/A
0.8
Target Price
N/A
16.9
N/A
64.7
N/A
19.2
28.9
8.0
19.6
Last Dividend Paid
N/A
0.5
180.0
2.0
N/A
N/A
0.25
0.4
N/A
Shares Owned By Institutions
N/A
31.42
0.09
48.49
N/A
60.0
82.04
5.03
56.61
Market Capitalization
23.76 M
8.46 B
3.67 B
29.24 B
34.19 M
3.13 B
10.43 B
378.51 M
3.16 B
Price To Earning
N/A
199.7
696.96
71.64
N/A
-3.8
17.22
18.58
10.2
Price To Earnings To Growth
N/A
N/A
N/A
1.77
N/A
0.07
0.21
N/A
N/A
Price To Sales
1000000.0
8.0
15672.58
0.49
412.48
0.56
0.54
6.38
0.41
Net Income
257.87 K
(229.18 M)
12.8 M
3.1 B
(7.82 M)
39.55 M
(581 M)
28.04 M
244.6 M
Earnings Per Share
-0.08
-0.1
11.79
5.8
-0.39
-0.99
-1.53
0.45
1.41
Shares Owned By Insiders
12.08
34.38
99.23
8.44
3.25
0.49
1.57
47.4
N/A
Revenue
N/A
774.35 M
200 K
51.2 B
N/A
3.44 B
15.47 B
64.32 M
6.43 B
Working Capital
N/A
332 M
298 M
4.93 B
N/A
1.03 B
663 M
139 M
N/A
Cash And Equivalents
2.7 M
628.91 M
1.66 B
6.6 B
4.97 M
1.24 B
156 M
140.86 M
2.13 B
Cash Per Share
N/A
1.17
N/A
12.52
0.29
109.51
3.37
2.43
17.53
Gross Profit
(101.62 K)
886 M
(1.2 M)
5.34 B
(766.61 K)
836.58 M
1.73 B
50 M
912.3 M
Day Typical Price
2.4
15.4
101.33
85.67
0.89
16.35
21.72
4.73
25.33
Accumulation Distribution
N/A
0.0078
0.0098
0.0037
0.033
0.0067
0.0236
0.0105
0.0102
Market Facilitation Index
N/A
0.12
1.0
0.32
0.03
0.11
0.52
0.05
0.26
Daily Balance Of Power
(9,223,372,036,855)
0.5833
(4.00)
0.5
(0.67)
0.7273
(0.56)
(0.60)
0.2308
Period Momentum Indicator
(0.10)
0.07
(4.00)
0.16
(0.02)
0.08
(0.29)
(0.03)
0.06
Rate Of Daily Change
0.96
1.0
0.96
1.0
0.98
1.0
0.99
0.99
1.0
Day Median Price
2.4
15.39
101.5
85.7
0.9
16.35
21.81
4.73
25.37
Price Action Indicator
(0.05)
0.055
(2.50)
(0.02)
(0.03)
0.045
(0.40)
(0.04)
(0.08)
Coefficient Of Variation
(664.46)
(1,162)
355.79
1819.35
437.19
671.39
755.81
934.43
1147.56
Mean Deviation
0.5994
0.7059
1387.49
0.9967
3.22
1.37
1.58
0.9816
1.48
Jensen Alpha
(0.24)
(0.1)
752.75
0.0627
0.9502
0.2789
0.3075
0.1286
0.1978
Total Risk Alpha
(0.30)
(0.14)
627.79
0.005
0.7523
0.1973
0.2026
0.0681
0.0863
Sortino Ratio
N/A
N/A
10.6
0.0203
0.2772
0.1259
0.1724
0.0756
0.0822
Downside Variance
N/A
N/A
4902.97
1.75
10.46
3.88
2.48
1.31
3.21
Standard Deviation
1.48
1.01
2641.99
1.3
4.11
1.96
2.39
1.23
2.2
Kurtosis
31.05
3.19
9.04
0.0402
2.54
2.08
8.83
(0.05)
7.9
Potential Upside
0.7042
1.38
9900.0
2.14
7.14
3.08
4.29
2.13
2.85
Treynor Ratio
(1.58)
(1.12)
(2.53)
(2.00)
(1.69)
2.64
(11.03)
(0.59)
(0.40)
Maximum Drawdown
13.57
6.57
9999.01
6.33
25.08
10.19
16.4
5.76
14.8
Variance
2.18
1.01
6980086.36
1.7
16.93
3.86
5.72
1.51
4.86
Market Risk Adjusted Performance
(1.57)
(1.11)
(2.52)
(1.99)
(1.68)
2.65
(11.02)
(0.58)
(0.39)
Risk Adjusted Performance
(0.12)
(0.07)
0.2347
0.0478
0.1909
0.125
0.1124
0.0891
0.076
Skewness
(4.59)
0.7745
3.28
0.125
0.9276
0.7006
2.07
0.3279
1.82
Semi Deviation
N/A
N/A
7.92
1.25
2.65
1.6
1.3
0.9732
1.57
Information Ratio
(0.18)
(0.13)
0.281
0.0206
0.2179
0.1262
0.1136
0.0706
0.0668
Value At Risk
(1.41)
(1.42)
(99.00)
(2.11)
(4.41)
(2.75)
(2.38)
(1.64)
(2.69)
Expected Short fall
N/A
N/A
(2,913)
(0.98)
(4.37)
(1.45)
(2.03)
(1.18)
(1.62)
Downside Deviation
N/A
N/A
70.02
1.32
3.23
1.97
1.58
1.15
1.79
Semi Variance
N/A
N/A
62.74
1.56
7.03
2.55
1.69
0.9472
2.46

AbL Diagnostics Competition Performance Charts

Five steps to successful analysis of AbL Diagnostics Competition

AbL Diagnostics' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by AbL Diagnostics SA in relation to its competition. AbL Diagnostics' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of AbL Diagnostics in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact AbL Diagnostics' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to AbL Diagnostics SA, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your AbL Diagnostics position

In addition to having AbL Diagnostics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Crypto And Gold Thematic Idea Now

Crypto And Gold
Crypto And Gold Theme
Assets that cancel away each other volatility by providing diversification into gold investment combined with digital assets. The Crypto And Gold theme has 54 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Crypto And Gold Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in AbL Stock

AbL Diagnostics financial ratios help investors to determine whether AbL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AbL with respect to the benefits of owning AbL Diagnostics security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY